Clinical

Timing of endoscopy for acute upper GI bleeding


 

Background: Prior studies have failed to show a benefit to earlier endoscopic intervention in acute GI bleeding. However, those studies were performed in all-comers without attention to the varying risk within the patient population.

Dr. Cheryl Lee, Division of Hospital Medicine, Northwestern University, Chicago

Dr. Cheryl Lee

Study design: Randomized controlled trial.

Setting: Single center in Hong Kong.

Synopsis: Patients at high risk for further bleeding or death by clinical score were randomized to endoscopy within 6 hours (“urgent endoscopy”), vs. the following day (“early endoscopy”), of GI consultation. Those who required immediate endoscopic intervention because of hemodynamic instability were excluded. All were prescribed proton-pump inhibitor drip, with the addition of vasoactive drugs and antibiotics if there was a suspected variceal bleed. There was no difference in 30-day mortality between the two groups – 8.9% with urgent endoscopy and 6.6% with early endoscopy (HR, 1.35; 95% CI, 0.72-2.54). There was no difference in length of hospital stay or the number of transfusions. Earlier endoscopy within 6 hours was associated with a higher number of actively bleeding lesions requiring intervention and a nonstatistical increase in recurrent bleeding within 30 days. It is believed that more time on proton-pump inhibitor infusion prior to endoscopy allows for stabilization of bleeds, thus requiring less intervention when endoscopy does occur.

Bottom line: Early endoscopy within 6 hours was not beneficial for those at high risk for rebleeding and death from upper GI bleed.

Citation: Lau JYW et al. Timing of endoscopy for acute upper gastrointestinal bleeding. N Engl J Med. 2020;382:1299-308. doi:10.1056/NEJMoa1912484.

Dr. Lee is a hospitalist at Northwestern Memorial Hospital and Lurie Children’s Hospital and assistant professor of medicine, Feinberg School of Medicine, all in Chicago.

Recommended Reading

Fact or fiction? Intravascular contrast and acute kidney injury
The Hospitalist
C. difficile guidelines offer new possibilities
The Hospitalist
Clostridioides difficile: Two sets of guidelines disagree
The Hospitalist
Acid suppression therapy increases intestinal colonization of MDROs
The Hospitalist
Antibiotic prophylaxis to prevent spontaneous bacterial peritonitis may not be effective
The Hospitalist
C. Diff eradication not necessary for clinical cure of recurrent infections with fecal transplant
The Hospitalist
COVID-19: New GI symptoms don’t raise death risk in IBD
The Hospitalist
Should hospitalists use albumin to treat non-SBP infections in patients with cirrhosis?
The Hospitalist
Rivaroxaban’s single daily dose may lead to higher bleeding risk than other DOACs
The Hospitalist
A pill for C. difficile works by increasing microbiome diversity
The Hospitalist
   Comments ()